<--GAT-->

Research Suggests Gout Drug Could Lower Diabetes Risk Among Veterans

by U.S. Medicine

December 6, 2015

NEW ORLEANS — Could a common drug used for gout lower the risk of diabetes?

That’s what a recent study in the journal Clinical Therapeutics endeavored to find out.1

The study team led by Tulane University researchers conducted a retrospective study of 27,876 adults with gout identified via the Veterans Integrated Services Network 16 data warehouse.

Patients in the study had up to 11 years of follow-up, from January 1999 through December 2010, and the final study sample consisted of 1,046 pairs of 1:1 propensity score-matched patients from the colchicine treated and control cohorts. The researchers’ focus was on time to first diabetes development since the first gout diagnosis was modeled.

Results indicate that, among the matched pairs, 234 veterans who had taken colchicine and 224 veterans who had never taken colchicine developed diabetes; the incidence rates were 38.95 and 39.02 per 1000 patient-years, respectively.

In Poisson and Cox proportional hazards regression, however, the risk of incident diabetes was reduced with increased duration of colchicine use, although the difference was not statistically significant. In further analysis, hazard ratio for incident diabetes among patients who had taken colchicine was 0.877 compared with those who had not taken colchicine.

“This study suggests a possible duration- or dose-related association between colchicine use and reduced risk of diabetes in adults with gout even though the risk reduction was not significant,” according to the study authors, who called for further studies to confirm their findings.

1 Wang L, Sawhney M, Zhao Y, Carpio GR, Fonseca V, Shi L. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout. Clin Ther. 2015 Jun 1;37(6):1206-15. doi: 10.1016/j.clinthera.2015.03.010. Epub 2015 Apr 7. PubMed PMID: 25857595.


Comments are closed here.


Related Articles

Personalization, In-Home Adaptation Necessary to Improve CPAP Adherence

INDIANAPOLIS—To improve adherence to continuous positive airway pressure treatment, more emphasis needs to be put on support for sleep apnea patients in their homes, where the equipment actually is used. That’s according to a new... View Article

Executive Order Creates Task Force to Combat Veteran Suicide

WASHINGTON—President Donald Trump has signed an executive order aimed at lowering the rate of veteran suicides. The order—the President’s Roadmap To Empower Veterans and End a National Tragedy of Suicide—creates a Cabinet-level task force led... View Article


U.S. Medicine Recommends


More From diabetes

Diabetes

Greatest VA Weight Gains in Women Veterans Without Diabetes

WASHINGTON—VA is straining its capacity and struggling against a culture that can sometimes be hostile to women as it responds to what VA officials consider a “tsunami wave of women veterans” over the last decade.... View Article

Diabetes

Diabetes Patients Do Well in Military Healthcare-to-VA Transition

WASHINGTON—VA is straining its capacity and struggling against a culture that can sometimes be hostile to women as it responds to what VA officials consider a “tsunami wave of women veterans” over the last decade.... View Article

Diabetes

NPs, PAs Have as Good Diabetes Outcomes as Physicians

WASHINGTON—VA is straining its capacity and struggling against a culture that can sometimes be hostile to women as it responds to what VA officials consider a “tsunami wave of women veterans” over the last decade.... View Article

Diabetes

Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events

WASHINGTON—VA is straining its capacity and struggling against a culture that can sometimes be hostile to women as it responds to what VA officials consider a “tsunami wave of women veterans” over the last decade.... View Article

Diabetes

Is Prandial Insulin or Noninsulin Agent Better for T2D Treatment Intensification?

Some veterans with type 2 diabetes patients can't reach their hemoglobin A1c goal despite using metformin, basal insulin and a sulfonylurea. What should come next?

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up